• 2026-05-08
• W.O. Adedeji
• Volume 2, Issue 1

Abstract

The challenge of a worldwide growing population, the rise of chronic diseases, an ageing population, as well as current global health challenges have sharply increased the need to have safe, efficient and quality pharmaceutical products. This study examined the impact of automation on efficiency, product quality, and regulatory compliance in pharmaceutical manufacturing. A cross-sectional survey research design was adopted to explore these relationships empirically. The collected data (333) were analysed using the Statistical Package for Social Sciences (SPSS). Descriptive statistics were used to summarise the data, while one-sample t tests were conducted to test hypotheses related to the significance of automation on efficiency, product quality, and compliance with pharmaceutical regulatory standards. The findings revealed that automation had a significant positive impact on manufacturing efficiency, notably by increasing production speed, reducing operational errors, and enhancing overall workflow. It also contributed to improved product quality and enabled consistent adherence to quality benchmarks. Furthermore, automation was shown to enhanced regulatory compliance through better data traceability, real-time monitoring, and automated documentation processes. Despite these benefits, the study identified some barriers, such as high initial investment costs, a shortage of skilled operators, employee resistance to change, and challenges in integrating automation. The study concluded that automation is a critical enabler of operational excellence in the pharmaceutical sector, with substantial benefits for efficiency, quality, and compliance.